129 related articles for article (PubMed ID: 8385237)
21. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
Luber B; Arnold N; Stürzl M; Höhne M; Schirmacher P; Lauer U; Wienberg J; Hofschneider PH; Kekulé AS
Oncogene; 1996 Apr; 12(8):1597-608. PubMed ID: 8622879
[TBL] [Abstract][Full Text] [Related]
22. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
23. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
24. Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA.
Zhang X; You X; Li N; Zhang W; Gagos S; Wang Q; Banos A; Cai N; Zhang H; Zhang H; Zhang X; Shan C; Qiu L; Zhang S; Lv N; Chen M; Du Y; Xia J; Ye L; Zhang X
FEBS Lett; 2012 Sep; 586(19):3215-21. PubMed ID: 22771476
[TBL] [Abstract][Full Text] [Related]
25. Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues.
Takada S; Koike K
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5628-32. PubMed ID: 2165598
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus and hepatocellular carcinoma: molecular biology and mechanistic considerations.
Sherman M; Shafritz DA
Semin Liver Dis; 1984 May; 4(2):98-112. PubMed ID: 6087462
[TBL] [Abstract][Full Text] [Related]
28. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
29. Transforming DNA sequences of human hepatocellular carcinomas, their distribution and relationship with hepatitis B virus sequence in human hepatomas.
Yang SS; Modali R; Parks JB; Taub JV
Leukemia; 1988 Dec; 2(12 Suppl):102S-113S. PubMed ID: 2848989
[TBL] [Abstract][Full Text] [Related]
30. Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas.
Tsuei DJ; Chang MH; Chen PJ; Hsu TY; Ni YH
J Med Virol; 2002 Dec; 68(4):513-21. PubMed ID: 12376959
[TBL] [Abstract][Full Text] [Related]
31. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
Shamay M; Agami R; Shaul Y
Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960
[TBL] [Abstract][Full Text] [Related]
32. [Hepatitis B virus integration and oncogene activation].
Koike K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2152-63. PubMed ID: 3038033
[TBL] [Abstract][Full Text] [Related]
33. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma.
Wang J; Zindy F; Chenivesse X; Lamas E; Henglein B; Bréchot C
Oncogene; 1992 Aug; 7(8):1653-6. PubMed ID: 1321406
[TBL] [Abstract][Full Text] [Related]
34. Viral co-factors in liver cancer: lessons from hepatitis B virus.
Butel JS; Lee TH; Slagle BL
Princess Takamatsu Symp; 1995; 25():185-98. PubMed ID: 8875624
[TBL] [Abstract][Full Text] [Related]
35. Activation of protooncogene c-jun by the X protein of hepatitis B virus.
Twu JS; Lai MY; Chen DS; Robinson WS
Virology; 1993 Jan; 192(1):346-50. PubMed ID: 8390762
[TBL] [Abstract][Full Text] [Related]
36. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
37. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
38. [X protein variations of genotype B and C hepatitis B virus isolated from the patients with hepatocellular carcinoma].
Xu X; Chen WN; Zheng DL; Huang QL; Lin X
Ai Zheng; 2004 Jul; 23(7):756-61. PubMed ID: 15248907
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.
Dejean A; Bougueleret L; Grzeschik KH; Tiollais P
Nature; 1986 Jul 3-9; 322(6074):70-2. PubMed ID: 3014347
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
